The Association Between Diabetes Mellitus During Pregnancy and Retinopathy of Prematurity

Lara Saaida1, Eilon Shany1,2, Ahed Imtirat1,3

  • 1Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Insights

This study found no significant link between maternal diabetes mellitus and retinopathy of prematurity in preterm infants. Further research is needed to understand risk factors for this condition.

Area of Science:

  • Neonatalogy
  • Ophthalmology
  • Endocrinology

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in preterm infants.
  • Diabetes mellitus (DM) in pregnancy is a growing concern, and its potential impact on ROP requires investigation.

Purpose of the Study:

  • To evaluate the association between maternal diabetes mellitus (DM) and the development of retinopathy of prematurity (ROP).
  • To identify risk factors for ROP in preterm infants born to mothers with and without DM.

Main Methods:

  • Retrospective nested case-control study of preterm infants (<32 weeks gestation or <1500 g birthweight) between 2013-2021.
  • Infants were grouped by ROP status; multivariable Generalized Estimating Equations (GEE) analyzed the association between ROP and maternal DM, adjusting for confounders.
  • Confounders included maternal age, diabetes type, gestational age, birthweight, oxygen duration, antenatal corticosteroids, and birth plurality.

Main Results:

  • The study included 881 mother-infant pairs; 39.1% of infants developed ROP.
  • Maternal DM was diagnosed in 6.4% of mothers in the ROP group versus 9.7% in the control group (p=0.082).
  • ROP was significantly associated with oxygen treatment, low birthweight (<1250 g), and advanced maternal age. Antenatal corticosteroids showed a protective effect.

Conclusions:

  • No statistically significant association was found between maternal diabetes mellitus and the risk of retinopathy of prematurity in this cohort.
  • Findings suggest other factors like oxygen exposure and birthweight are more critical in ROP development.
  • Cautions regarding the retrospective design and limited glycemic control data are noted.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.4K